Treatment group

Control group

Patients with recurrence during 0 m - 3 m follow-up

5(13.5%)^*

9(32.1%)

Patients with recurrence during 3 m - 6 m follow-up

2(5.4%)^*

4(14.3%)

Total patients with recurrence

7(18.9%)^*

13(46.4%)